StonvexLoading…
StonvexStonvexStonvexCore line items from PMCB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-04-30 | Annual 2024 2024-04-30 | Annual 2023 2023-04-30 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-4.38M | $-8.52M | $-6.46M | $-4.39M |
Net Income | $30.66M | $333.76K | $-4.32M | $-4.24M |
EPS (Diluted) | $3.19 | $-1.80 | $-0.22 | $-0.27 |
Total Assets | $55.17M | $59.90M | $73.28M | $90.62M |
Total Liabilities | $3.28M | $20.39M | $586.58K | $704.37K |
Cash & Equivalents | $15.17M | $50.18M | $68.04M | $85.40M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 6.80M | 8.04M | 16.79M | 20.72M |